Skip to content

Clinical trials

Phase 2 Rhabdomyosarcoma trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Rhabdomyosarcoma Phase: Phase 2 Clear all

81 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20023
20035
20051
20063
20074
20084
20092
20102
20111
20123
20134
20142
20153
20163
20177
20184
20191
20204
20213
20225
20232
20243
20251
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed41
Active, not recruiting14
Recruiting7
Terminated6
Unknown status6
Withdrawn5
Not yet recruiting2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Cancer Institute (NCI)24
European Organisation for Research and Treatment of Cancer - EORTC5
Memorial Sloan Kettering Cancer Center4
St. Jude Children's Research Hospital4
Children's Oncology Group3
Fudan University3
Brown University2
Children's National Research Institute2
City of Hope Medical Center2
Eli Lilly and Company2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Rhabdomyosarcoma81
Sarcoma54
Osteosarcoma38
Sarcoma, Ewing36
Neuroblastoma32
Neuroectodermal Tumors, Primitive, Peripheral22
Wilms Tumor22
Medulloblastoma20
Ependymoma17
Hepatoblastoma17

Trials

Showing 1 to 25 of 81. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.